In addition, in the 28 day preliminary study, the Bioglutid treatment form showed a weight loss of up to 6.4%, and maintained a weight loss of 5.3% 7 days after discontinuation, indicating that its weight loss effect is sustained and stable
Clinicians should be aware that even if a hypothyroid patient is being treated with L-T4, a number of studies have found that giving selenium as well as L-T4 resulted in a greater reduction in TPO-antibodies, inflammatory cytokines and C-reactive protein ( Reference Krysiak and Okopien 104 , Reference Duntas, Mantzou and Koutras 105 )
More on this in the management section below
Ozempic for weight loss is intended to be a long-term treatment, so when used safely, patients will likely take over a year before they are able to reach their goal weight
The addition of the GIP component is what distinguishes tirzepatide from semaglutide